Objective: In recent years, endovascular and hybrid therapies have come to the forefront in the treatment of peripheral arterial disease (PAD) instead of open surgical treatment. In this study, we aimed to present the results of endovascular and hybrid treatments performed in our newly established clinic.

Methods: The data of the patients, who were diagnosed as PAD and treated with endovascular and hybrid methods, were retrospectively analyzed and 50 patients were included in the study. Patients were classified according to the Fontaine classification and patients with Fontaine 2B or higher underwent interventional or hybrid treatment.

Results: The majority of the patients were male (96%) and mean age of the patients was 62.89±9.01 years. Twelve patients (24%) had ischemic ulcers (Fontaine 4), 32 patients (64%) had claudication (Fontaine 2B) and six patients (12%) had rest pain (Fontaine 3). Thirty-four patients (68%) underwent endovascular intervention and 16 (32%) underwent hybrid treatment procedures. In 38 patients (76%) with complaints of Fontaine class 2B or 3 before the intervention, symptoms regressed to Fontaine class 1 after the procedure. The mean ankle-brachial index values of the extremities with lesions increased from 0.44±0.30 to 0.85±0.17 on the first postoperative day.

Conclusion: In conclusion, endovascular and hybrid interventions provide satisfactory results in high-risk patients with PAD for both the salvage of extremities and the improvement of symptoms. We believe that endovascular interventions will provide less invasive and safer revascularization in patients with higher comorbidity rates in the future.